Home Healthcare IT Germany Cell and Gene Therapy Manufacturing QC Market Size, Share And Growth Report By 2028

Germany Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028

Germany Cell and Gene Therapy Manufacturing QC Market Size

According to Straits Research analysis, the Germany Cell and Gene Therapy Manufacturing QC Market was valued at USD 62.34 Million in 2024 and is projected to reach USD 151.28 Million by 2028, expanding at a CAGR of 24.9% during the forecast period. Primary demand is driven by industries such as agriculture, chemicals, and energy, where these therapies are utilized for crop enhancement, genetic modification, and renewable energy development, respectively. Technological advancements in the cell and gene sector are the key to market growth, coupled with Germany’s focus on environmentally-friendly, low-carbon production processes that bolster sustainability. As the nation broadens its export portfolio, potential job creation may fuel further expansion. With a forward-thinking approach, Germany is positioning itself as a hub for innovation and sustainability within the global cell and gene therapy market.

Germany Cell and Gene Therapy Manufacturing QC Market Highlights

  • Within the Therapy Type category, Cell Therapy dominated in 2024 in terms of market size contribution.
  • Over the forecast period, Gene Therapy is forecasted to deliver the fastest growth, positioning it as the most lucrative Therapy Type segment.
  • As of 2024, Germany held 2.79% of the global cell and gene therapy manufacturing qc market size.
  • By 2028, United States is anticipated to capture the largest share of the global cell and gene therapy manufacturing qc market.
  • In Europe, Germany is expected to lead the regional cell and gene therapy manufacturing qc market size by 2028.
  • France will remain the fastest-growing market in Europe, reaching USD 45534 Million by 2028.
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2028
Historical Period 2021-2023
Forecast Period 2025-2028
Market Size In 2024 USD 62.34 Million
Market Size In 2028 USD 151.28 Million
Largest segment Cell Therapy
Fastest segment Gene Therapy
Units Revenue in USD Million
CAGR 24.9% (2025-2028)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Germany Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type

Segmentation Covered

Segments Sub Segments
Therapy Type
  1. Cell Therapy
  2. Gene Therapy
Cell Therapy
  1. CAR-T
  2. CAR-NK
  3. B-Cell
  4. Other
CAR-T
  1. Autologous CAR-T
  2. Allogeneic CAR-T
Gene Therapy
  1. Viral
  2. Non-Viral
Viral
  1. AAV
  2. Lentiviral vectors
  3. Other
Scale
  1. Pre commercial/ R&D Manufacturing
  2. Commercial Scale Manufacturing
Mode
  1. Contract Manufacturing
  2. In-house Manufacturing
Workflow
  1. Cell Processing
  2. Cell Banking
  3. Fill & Finish Operations
  4. Raw Material Testing
  5. Vector Production
  6. Other Workflows
Process
  1. Upstream Processes
  2. Downstream Processes
End User
  1. Pharmaceutical Companies
  2. Biopharmaceutical / Biotechnological Companies
  3. Contract Manufacturing Organizations
Pharmaceutical Companies
  1. Small Size
  2. Medium Size
  3. Large Size
Biopharmaceutical / Biotechnological Companies
  1. Small Size
  2. Medium Size
  3. Large Size
Contract Manufacturing Organizations
  1. Small Size
  2. Medium Size
  3. Large Size
Technology Type
  1. Fluorescence-Activated Cell Sorting (FACS)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Chromatography
  4. Next-Generation Sequencing (NGS)
  5. Polymerase Chain Reaction (PCR)
  6. Others 

Cell and Gene Therapy Manufacturing QC Market- Geographics


WhatsApp
Chat with us on WhatsApp